SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on speculation that SELLASs Phase 3 REGAL AML trial is nearing its final event trigger and subsequent topline analysis, with traders reacting to CEO commentary and favorable remarks from pharmaceutical-industry professionals. The community remains sharply divided: bulls view the prolonged survival and outside commentary as supportive, while bears question the trial design, delayed event timing, and likelihood of a successful readout.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Preliminary second-quarter results showing sharply improved operating profitability despite lower revenue, together with an amended convertible-note exchange that limits stock issuance and shifts the remainder to cash, are driving attention. Traders are divided between viewing the developments as evidence of improving fundamentals and reduced dilution risk, and focusing on revenue declines, management concerns, and unusual warrant activity that has fueled speculative squeeze discussion.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Celina, Texass reported conversion of its city WiFi into Helium-powered carrier coverage is driving attention, with traders viewing the deployment and broader carrier-offload use case as evidence of real-world DePIN adoption. Bullish commenters expect continued momentum, while skeptics question token dilution, hotspot profitability, and whether network usage will translate into value for HNT holders.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Anticipation of broader federal marijuana rescheduling to Schedule III, including an upcoming administrative-law recommendation, is driving attention as traders expect reduced tax burdens and improved institutional access for U.S. cannabis operators. The community remains largely bullish on Trulieves positioning and NYSE listing, while others warn that the catalyst is not yet finalized and cite profit-taking, overbought conditions, and post-earnings concerns.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Strong Phase 3 data for CAN-2409 in localized prostate cancer, along with anticipation of ASTRO findings and a planned Q4 BLA submission, is driving bullish attention. Traders see potential regulatory and pharmaceutical-partnership upside, while skeptics point to dilution risk, the unfiled BLA, profit-taking, and broader biotech momentumincluding enthusiasm around cancer-vaccine developmentsas competing factors.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Positive Phase 3 SHASTA-3 and SHASTA-4 results for plozasiran in severe hypertriglyceridemia, including substantial triglyceride reductions and fewer acute pancreatitis events, are driving attention and expectations for a broader regulatory filing. Traders are broadly bullish on REDEMPLOs commercial potential and Arrowheads RNAi platform, although some debate the valuation, competition from Ionis, and the stocks volatile sell-the-news trading.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Reports of renewed U.S.-Iran hostilities, tanker attacks, and severely disrupted Strait of Hormuz flows are driving attention to USO, with traders debating whether the supply shock will lift crude prices. The Venezuela oil agreement and possible diplomatic reopening are viewed by bears as longer-term supply relief, while bulls argue infrastructure limits mean they will not quickly offset the disruption.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Upcoming quarterly earnings are the dominant catalyst, with traders focused on whether Broadcoms AI custom-chip and networking demand will support stronger guidance. Bulls expect a beat and continued momentum from OpenAI and hyperscaler projects, while bears argue expectations are already elevated and remain concerned about debt, potential Google-related share loss, and another post-earnings selloff.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Canadian government funding for Xanadus quantum-manufacturing Project OPTIMISM is driving attention, while traders debate whether additional federal and Ontario support will materialize. The community is split between viewing the backing as validation of Xanadus photonic technology and warning that heavy cash burn, limited revenue, and potential dilution could offset the benefit.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Ongoing buyout speculation is the dominant topic, with traders pointing to Vandas approved products, NEREUSs potential as a GLP-1 nausea treatment, and the broader pharmaceutical M&A environment. The community remains divided, as optimism about the pipeline and perceived undervaluation competes with concerns over management, heavy spending, cash burn, and possible dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fox Corporation President and Chief Operating Officer John Nallen to Participate in Upcoming Goldman Sachs Communacopia + Technology Conference 2026

Fox Corporation President and Chief Operating Officer John Nallen to Participate in Upcoming Goldman Sachs Communacopia + Technology Conference 2026 Fox Corporation President and Chief Operating Officer John Nallen to Participate in Upcoming Goldman Sachs Communacopia + Technology Conference 2026...

FOX Q4 Earnings Call Focuses on Ad Momentum and Digital Growth

FOX enters fiscal 2027 with strong ad demand, rising Tubi engagement and FOX One growth, while the World Cup and midterms support momentum.

Roku Releases Second Quarter 2026 Financial Results

Today, Roku, Inc. (NASDAQ: ROKU) released second quarter 2026 results. Visit the Roku investor relations website to view the second quarter 2026 letter to shareholders. On June 15, 2026, Fox Corporation (Nasdaq: FOXA, FOX) and Roku announced a definitive agreement under which FOX will acquire Roku...

Fox Says 2026 World Cup Fueled Subscriber Growth Beyond Expectations

Fox Corp stock rises on Q4 FY26 earnings beat! World Cup ads & streaming gains boost revenue 28% to $4.21B.read more...

Fox Corporation (FOX) Surpasses Q4 Earnings and Revenue Estimates

Fox (FOX) delivered earnings and revenue surprises of +33.58% and +17.01%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Roku Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Roku Inc. (NASDAQ: ROKU) will report Q2 earnings on Aug. 6. Analysts expect earnings of 56 cents per share and revenue of $1.3 billion. Fox Corporation (NASDAQ: FOXA) is set to acquire Roku for $22B. Analysts have mixed ratings on the stock.read more...

Fox Corporation Q4 Sales Increase

(RTTNews) - Fox Corporation (FOXA) announced a profit for fourth quarter of $691 million...

FOX REPORTS FOURTH QUARTER FISCAL 2026 REVENUE OF $4.21 BILLION, NET INCOME OF $696 MILLION, AND ADJUSTED EBITDA OF $1.20 BILLION

FOX REPORTS FOURTH QUARTER FISCAL 2026 REVENUE OF $4.21 BILLION, NET INCOME OF $696 MILLION, AND ADJUSTED EBITDA OF $1.20 BILLION FOX REPORTS FOURTH QUARTER FISCAL 2026 REVENUE OF $4.21 BILLION, NET INCOME OF $696 MILLION, AND ADJUSTED EBITDA OF $1.20 BILLION PR Newswire NEW YORK, Aug. 6, 2026 FOX...

Central Garden (CENTA) Tops Q3 Earnings and Revenue Estimates

Central Garden (CENTA) delivered earnings and revenue surprises of +1.99% and +0.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Fox Corporation (FOX) Q4 Earnings Expected to Decline

Fox (FOX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

• Reported GAAP EPS of $1.61 up 2.55% YoY
• Reported revenue of $4.21B up 28.14% YoY

Fox Corporation experienced a decrease in net income for both the quarter and full fiscal year, while the Cable Network Programming segment faced the structural challenge of net subscriber declines.

Fox Corporation achieved significant revenue growth driven by the FIFA Men's World Cup, while strategically expanding its digital footprint through the launch of FOX One and the announced Roku acquisition.

Fox Corp. engages in providing television production and broadcasting services. It also provides news under the brands FOX News Media, FOX Sports, FOX Entertainment and FOX Television Stations, and Tubi Media Group. It operates through the following segments: Cable Network Programming, Television, and Other and Corporate. The Cable Network Programming segment refers to the production and licensing of news and sports content distributed primarily through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies and online multi-channel video programming distributors. The Television segment focuses on the acquisition, marketing, and distribution of broadcast network programming. The Other and Corporate segment relates to the FOX Studio Lot, Credible Labs Inc, corporate overhead costs, and intracompany eliminations. The company was founded by Keith Rupert Murdoch on May 3, 2018 and is headquartered in New York, NY.

Fox Corporation - Ordinary Shares - Class B

NFLX, DIS, YouTube Want FIFA's World Cup US Rights — Why A $2B Bidding War Is Brewing

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '27	$2.06	--	--	N/A
Q4 '26	$1.44	$1.79	24.56%	BEAT
Q3 '26	$0.99	$1.32	33.65%	BEAT
Q2 '26	$0.50	$0.82	64.34%	BEAT
Q1 '26	$1.11	$1.51	36.39%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '26

Historical Earnings